Testing a short course for adults with chronic fatigue syndrome
Compares a 3-day course with a waiting list in adults with ME/CFS.
Plain-language title generated from the registry record
Registry title: A 3-day Course for CFS/ME
Key facts
- Where
- Trondheim, NorwaySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT05236465, who can take part
Where in Norway
- Department of Psychology, NTNUTrondheim, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Norwegian University of Science and Technology
- Trial code
- NCT05236465
- Record updated
- 26 November 2025
- Original description
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem.Read full original descriptionShow less
A 3-day Course for Adults With Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME): a Randomized Controlled Trial
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem.
In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures.
There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed.
If the 3-day course shows promising effects, this could have positive consequences for patients, relatives and health personnel, but also financially for the society and the municipality.
Inclusion: CFS/ME diagnosis based on the Canada Consensus Criteria; At least 50% out of school/work; Readiness to change (corresponding to the preparation phase in transtheoretical model); Has given informed consent.
Exclusion: Suicide risk/previous suicide attempts; Underlying physical illness or mental disorder that may explain the symptoms; Assessed by a General Practitioner (GP):; Pregnancy; Bedridden and in need of continuous care; Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.